[Renin-aldosterone system in patients with hypertensive form of chronic glomerulonephritis and preserved renal

Klinicheskaia Meditsina
|October 16, 2009
PubMed

Insights

In chronic glomerulonephritis (CGN) patients with normal kidney function, plasma active renin (PAR) levels correlate with hypertension severity. Elevated plasma aldosterone (PAL) also appears in severe hypertension, suggesting a role for the renin-aldosterone system in CGN-related high blood pressure.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Chronic glomerulonephritis (CGN) can affect kidney function and blood pressure.
  • The renin-aldosterone system plays a crucial role in regulating blood pressure.
  • Understanding its role in CGN with preserved renal function is important for managing hypertension.

Purpose of the Study:

  • To assess the renin-aldosterone system's status in patients with hypertonic chronic glomerulonephritis (CGN) and preserved renal function.
  • To investigate the correlation between renin-aldosterone system activity and the severity of arterial hypertension (AH) in these patients.

Main Methods:

  • Radioimmunoassay (RIA) was used to measure plasma active renin (PAR) and plasma aldosterone (PAL) levels.
  • 100 patients with hypertonic CGN and preserved renal function were studied.
  • A control group of 35 CGN patients without arterial hypertension was included.

Main Results:

  • In normotensive CGN patients with preserved renal function, PAR and PAL levels were unaltered.
  • PAR levels tended to increase in CGN patients with AH and correlated with AH severity.
  • PAL levels were significantly elevated in CGN patients with grade II and III AH.

Conclusions:

  • Elevated PAR levels likely play a significant role in the development of arterial hypertension in CGN patients with preserved renal function.
  • A trend towards increased PAL levels was observed in these hypertensive CGN patients.
  • The renin-aldosterone system is implicated in the pathogenesis of hypertension in CGN.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...